Tech Company Financing Transactions
Ace Vision Group Funding Round
Ace Vision Group, based in Newark, received $13.3 million from private investors.
Transaction Overview
Company Name
Announced On
1/22/2021
Transaction Type
Venture Equity
Amount
$13,300,000
Round
Series A
Investors
private investors (Lead Investor) (Robert Picerne)
Proceeds Purpose
The funds from this round will be used to continue development and commercialization of its innovative VisioLite Ophthalmic Laser.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
39655 Eureka Dr.
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Not Recorded
Overview
Ace Vision's Mission is to be the leader in developing innovative eye laser therapeutic technologies to heal age-related eye dysfunction and restore the eye's natural performance for more youthful vision. LaserACE is the only therapeutic eye laser treatment that restores function naturally without involving vision correction, artificial implant or devices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
AnnMarie Hipsley
Vice President
David Neal
VP - Bus. Development
Donald Robinson
VP - General Counsel
Bruce Feuchter
VP - Operations
Eddie Hsiao
VP - Product Management
Robert Barry
VP - R & D
Brad Hall
VP - Regulatory Affairs
Robert Seiple
Browse more venture capital transactions:
Prev: 1/22/2021: Plexium venture capital transaction
Next: 1/22/2021: Omnipresent venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs